I’ve been thinking a lot about the nature of risk, both in the world of IVF and in the startup ecosystem. Each domain has its own unique set of uncertainties, but a recent experience in my IVF practice brought a new perspective that has influenced how I approach risk-taking in startups.
Not long ago, I faced a difficult decision with a patient undergoing IVF. We were at a crossroads: proceed with transferring a single embryo or opt for a double transfer to increase the odds. The couple was understandably anxious — like many founders at the precipice of launching a new venture, they were torn between the fear of failure and the hope of success. The decision wasn’t just about numbers; it was about understanding and weighing the risks, much like any investment decision.
In the end, we chose to transfer a single embryo. The outcome was positive, but the process reminded me of the stark parallels between IVF and startup investing. Both involve placing a bet on potential — an embryo or an idea — with no guarantees of success. It’s a dance with uncertainty that demands careful consideration of risk versus reward.
In many ways, the way we approached that IVF decision has reshaped how I view risk in startups. In the past, I might have been tempted to spread my bets, investing in multiple ventures with the hope that one would succeed. However, this experience taught me the value of focusing on quality over quantity. Just as transferring two embryos doesn’t double the chances of success without increasing risk, spreading investments too thin can dilute focus and resources.
One of the key aspects of both IVF and startup investing is managing expectations. In IVF, patients often come with hopes fueled by success stories they’ve heard from others. Similarly, many startup founders are captivated by tales of overnight success, which are often exaggerated. I’ve always believed in the importance of setting realistic expectations, as I discussed in a previous post, “What Indian Startups Can Learn from IVF Patients About Managing Expectations”.
In both fields, it’s crucial to acknowledge the role of failure. In IVF, not every cycle leads to pregnancy, and in startups, not every venture leads to a successful exit. Understanding this reality allows us to embrace failure as a learning opportunity, rather than a setback. This mindset is something I explored further in another piece, “How Honest Failures in IVF Helped Me Mentor Startups Better”.
The parallels don’t end there. IVF and startups both thrive on uncertainty — a concept I delved into in “Desperately Seeking Certainty: Why IVF and Startups Both Thrive on Uncertainty”. In both arenas, we are constantly trying to predict outcomes with limited data. The unpredictability is part of the allure, but it also demands resilience and adaptability.
Consider the concept of “fetal personhood” laws that I recently encountered in my practice, which classify embryos as people. This legal landscape introduces new complexities and risks for IVF practitioners and patients. Similarly, startups often face regulatory hurdles that can impact their trajectory. Navigating these challenges requires a deep understanding of the landscape and the ability to pivot when necessary.
In the startup world, the temptation to follow trends and mimic successful models is strong, but true innovation requires forging a unique path — much like how every IVF journey is distinct. The lesson here is to embrace individuality and resist the pressure to conform to what has worked for others.
One might ask, how do we deal with the pressure of these high-stakes decisions? In IVF, it’s about providing comprehensive counseling and support to help patients make informed choices. In startups, it’s about mentoring founders to understand the risks and rewards of their decisions, ensuring they are prepared for the journey ahead.
The takeaway from my recent IVF experience is that risk-taking, whether in reproductive medicine or investing, should be deliberate and informed. It’s not about playing it safe, but rather about making calculated decisions that align with one’s goals and values.
In conclusion, the IVF decision that reshaped my approach to startups wasn’t just a clinical choice; it was a reminder of the power of thoughtful decision-making. As I continue to navigate both worlds, I carry this lesson with me: success is not about avoiding risk, but about embracing it with clarity and purpose.